Atypical antipsychotics in the treatment of delirium

Psychiatry and Clinical Neurosciences

Volumn 67, Issue 5, 2013, Pages 323-331

  Wang, Hee Ryung ^a   Woo, Young Sup ^a   Bahk, Won Myong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

atypical antipsychotic; delirium; efficacy; safety; treatment

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ABSENCE OF SIDE EFFECTS; CLINICAL GLOBAL IMPRESSION SCALE; DELIRIUM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LOW DRUG DOSE; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ATYPICAL ANTIPSYCHOTIC; DELIRIUM; EFFICACY; SAFETY; TREATMENT;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DELIRIUM; DIBENZOTHIAZEPINES; HUMANS; PIPERAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE; SULPIRIDE; THIAZOLES;

EID: 84880289268     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12066     Document Type: Review

References (64)

1. Ozbolt LB, Paniagua MA, Kaiser RM,. Atypical antipsychotics for the treatment of delirious elders. J. Am. Med. Dir. Assoc. 2008; 9: 18-28.
2. Lipowski ZJ,. Delirium (acute confusional states). JAMA 1987; 258: 1789-1792.
3. Han CS, Kim YK,. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301.
4. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am. J. Psychiatry 1999; 156: 1-20.
5. Alici Y, Breitbart W,. Delirium in palliative care. Prim. Psychiatry 2009; 16: 42-48.
6. Meagher DJ,. Delirium: Optimising management. BMJ 2001; 322: 144-149.
7. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK,. Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence. J. Gerontol. A. Biol Sci. Med Sci. 2008; 63: 764-772.
8. Seitz DP, Gill SS, van Zyl LT,. Antipsychotics in the treatment of delirium: A systematic review. J. Clin. Psychiatry 2007; 68: 11-21.
9. Bledowski J, Trutia A,. A review of pharmacologic management and prevention strategies for delirium in the intensive care unit. Psychosomatics 2012; 53: 203-211.
10. Tandon R, Jibson MD,. Extrapyramidal side effects of antipsychotic treatment: Scope of problem and impact on outcome. Ann. Clin. Psychiatry 2002; 14: 123-129.
11. Boettger S, Breitbart W,. Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliat. Support. Care 2005; 3: 227-237.
12. Peritogiannis V, Stefanou E, Lixouriotis C, Gkogkos C, Rizos DV,. Atypical antipsychotics in the treatment of delirium. Psychiatry Clin. Neurosci. 2009; 63: 623-631.
13. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S,. The memorial delirium assessment scale. J. Pain Symptom Manage. 1997; 13: 128-137.
14. Trzepacz PT, Baker RW, Greenhouse J,. A symptom rating scale for delirium. Psychiatry Res. 1988; 23: 89-97.
15. McCusker J, Cole M, Bellavance F, Primeau F,. Reliability and validity of a new measure of severity of delirium. Int. Psychogeriatr. 1998; 10: 421-433.
16. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N,. Validation of the Delirium Rating Scale-revised-98: Comparison with the delirium rating scale and the cognitive test for delirium. J. Neuropsychiatry Clin. Neurosci. 2001; 13: 229-242.
17. Lee KU, Won WY, Lee HK, et al. Amisulpride versus quetiapine for the treatment of delirium: A randomized, open prospective study. Int. Clin. Psychopharmacol. 2005; 20: 311-314.
18. Skrobik YK, Bergeron N, Dumont M, Gottfried SB,. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med. 2004; 30: 444-449.
19. Grover S, Kumar V, Chakrabarti S,. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J. Psychosom. Res. 2011; 71: 277-281.
20. Tahir TA, Eeles E, Karapareddy V, et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J. Psychosom. Res. 2010; 69: 485-490.
21. Kim SW, Yoo JA, Lee SY, et al. Risperidone versus olanzapine for the treatment of delirium. Hum. Psychopharmacol. 2010; 25: 298-302.
22. Pintor L, Fuente E, Bailles E, Matrai S,. Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital. Eur. Psychiatry 2009; 24: 450-455.
23. Guy W,. Clinical global impressions. In:, Guy W, (ed.). ECDEU Assessment Manual for Psychopharmacology, Revised. National Institute of Mental Health, Rockville, MD, 1976; 217-222.
24. Kim KS, Pae CU, Chae JH, Bahk WM, Jun T,. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin. Neurosci. 2001; 55: 515-519.
25. Breitbart W, Tremblay A, Gibson C,. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43: 175-182.
26. Lin CJ, Sun FJ, Fang CK, Chen HW, Lai YL,. An open trial comparing haloperidol with olanzapine for the treatment of delirium in palliative and hospice center cancer patients. J. Intern. Med. Taiwan 2008; 19: 346-354.
27. Citrome L,. Olanzapine pamoate: A stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic. Int. J. Clin. Pract. 2009; 63: 140-150.
28. Alao AO, Moskowitz L,. Aripiprazole and delirium. Ann. Clin. Psychiatry 2006; 18: 267-269.
29. Sipahimalani A, Masand PS,. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39: 422-430.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edn (DSM-IV). American Psychiatric Association, Washington, DC, 1994.
31. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI,. Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann. Intern. Med. 1990; 113: 941-948.
32. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K,. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. 1987; 334 (Suppl): 1-100.
33. Schwartz TL, Masand PS,. Treatment of delirium with quetiapine. Prim. Care Companion J. Clin. Psychiatry 2000; 2: 10-12.
34. Kim KY, Bader GM, Kotlyar V, Gropper D,. Treatment of delirium in older adults with quetiapine. J. Geriatr. Psychiatry Neurol. 2003; 16: 29-31.
35. Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J. Clin. Psychiatry 2003; 64: 1316-1321.
36. Pae CU, Lee SJ, Lee CU, Lee C, Paik IH,. A pilot trial of quetiapine for the treatment of patients with delirium. Hum. Psychopharmacol. 2004; 19: 125-127.
37. Maneeton B, Maneeton N, Srisurapanont M,. An open-label study of quetiapine for delirium. J. Med. Assoc. Thai. 2007; 90: 2158-2163.
38. Khouzam HR,. Quetiapine in the treatment of postoperative delirium. A report of three cases. Compr. Ther. 2008; 34: 207-217.
39. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit. Care Med. 2010; 38: 419-427.
40. Flemenbaum A, Zimmermann RL,. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol. Rep. 1973; 32: 783-792.
41. Folstein MF, Robins LN, Helzer JE,. The mini-mental state examination. Arch. Gen. Psychiatry 1983; 40: 812.
42. Smith JM, Kucharski LT, Eblen C, Knutsen E, Linn C,. An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology (Berl) 1979; 64: 99-104.
43. Boettger S, Breitbart W, Passik S,. Haloperidol and risperidone in the treatment of delirium and its subtypes. Eur. J. Psychiatry 2011; 25: 59-67.
44. Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary. Society of Critical Care Medicine. Crit. Care Med. 1995; 23: 1596-1600.
45. Spitzer RL, Williams JB, Gibbon M, First MB,. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatry 1992; 49: 624-629.
46. Toda H, Kusumi I, Sasaki Y, Ito K, Koyama T,. Relationship between plasma concentration levels of risperidone and clinical effects in the treatment of delirium. Int. Clin. Psychopharmacol. 2005; 20: 331-333.
47. Ushijima M, Yokoyama S, Sugiyama E, Amano N,. Contribution of perospirone and risperidone to reduce delirium in senile patients. Psychogeriatrics 2008; 8: 4-7.
48. Sipahimalani A, Masand PS,. Use of risperidone in delirium: Case reports. Ann. Clin. Psychiatry 1997; 9: 105-107.
49. Leso L, Schwartz TL,. Ziprasidone treatment of delirium. Psychosomatics 2002; 43: 61-62.
50. Young CC, Lujan E,. Intravenous ziprasidone for treatment of delirium in the intensive care unit. Anesthesiology 2004; 101: 794-795.
51. Jung SW,. Ziprasidone for the treatment of delirium: Case studies. Clin. Psychopharmacol. Neurosci. 2010; 8: 111-114.
52. Girard TD, Pandharipande PP, Carson SS, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit. Care Med. 2010; 38: 428-437.
53. Alao AO, Soderberg M, Pohl EL, Koss M,. Aripiprazole in the treatment of delirium. Int. J. Psychiatry Med. 2005; 35: 429-433.
54. Boettger S, Breitbart W,. An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients. Palliat. Support. Care 2011; 9: 351-357.
55. Straker DA, Shapiro PA, Muskin PR,. Aripiprazole in the treatment of delirium. Psychosomatics 2006; 47: 385-391.
56. Boettger S, Friedlander M, Breitbart W, Passik S,. Aripiprazole and haloperidol in the treatment of delirium. Aust. N. Z. J. Psychiatry 2011; 45: 477-482.
57. Yoon HK, Kim YK, Han C, et al. Paliperidone in the treatment of delirium: Results of a prospective open-label pilot trial. Acta Neuropsychiatr. 2011; 23: 179-183.
58. Cha DS, McIntyre RS,. Treatment-emergent adverse events associated with atypical antipsychotics. Expert Opin. Pharmacother. 2012; 13: 1587-1598.
59. Morita T, Tei Y, Shishido H, Inoue S,. Olanzapine-induced delirium in a terminally ill cancer patient. J. Pain Symptom Manage. 2004; 28: 102-103.
60. Samuels S, Fang M,. Olanzapine may cause delirium in geriatric patients. J. Clin. Psychiatry 2004; 65: 582-583.
61. Lim CJ, Trevino C, Tampi RR,. Can olanzapine cause delirium in the elderly? Ann. Pharmacother. 2006; 40: 135-138.
62. Tavcar R, Demovsek MZ,. Risperidone-induced delirium. Can. J. Psychiatry 1998; 43: 194.
63. Aggarwal A, Sharma RC,. Delirium associated with olanzapine therapy in an elderly man with bipolar affective disorder. J. Neuropsychiatry Clin. Neurosci. 2011; 23: E54-E55.
64. Miodownik C, Alkatnany A, Frolova K, Lerner V,. Delirium associated with lithium-quetiapine combination. Clin. Neuropharmacol. 2008; 31: 176-179.